Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies - NovoCure  ( NASDAQ:NVCR ) , Zai Lab  ( NASDAQ:ZLAB )